DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 04 · Volume 117 · 2017 DOI: 10.1055/s-007-35260

Invited Editorial Focus

647
Roldan, Vanessa; Marín, Francisco: Predicting bleeding risk after coronary surgery: Let’s focus on modifiable risk factors and simple, practical decision making

T&H Insights

650
David, Sprott; Chavakis, Triantafyllos: A BMP4-angiomiR connection in angiogenesis

Review Article

651
Stocker, Thomas J.; Hellen, Ishikawa-Ankerhold; Steffen, Massberg; Christian, Schulz: Small but mighty: Platelets as central effectors of host defense

Coagulation and Fibrinolysis

662
Fonseca, Roberto J.C.; Sucupira, Isabela D.; Oliveira, Stephan Nicollas M.C.G.; Santos, Gustavo R.C.; Mourão, Paulo A.S.: Improved anticoagulant effect of fucosylated chondroitin sulfate orally administered as gastroresistant tablets
Zusatzmaterial
671
Ivanov, Ivan; Shakhawat, Ruhama; Sun, Mao-fu; Dickeson, S. Kent; Puy, Cristina; McCarty, Owen J.T; Gruber, Andras; Matafonov, Anton; Gailani, David: Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen
Zusatzmaterial
682
Brzoska, Tomasz; Suzuki, Yuko; Sano, Hideto; Suzuki, Seiichirou; Tomczyk, Martyna; Tanaka, Hiroki; Urano, Tetsumei: Imaging analyses of coagulation-dependent initiation of fibrinolysis on activated platelets and its modification by thrombin-activatable fibrinolysis inhibitor
Zusatzmaterial
691
Kumar, Monisha; Cao, Wenjing; McDaniel, Jenny K.; Pham, Huy P.; Raju, Dheeraj; Nawalinski, Kelsey; Frangos, Suzanne; Kung, David; Zager, Eric E.; Kasner, Scott E.; Levine, Joshua M.; Long Zheng, X.: Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage
700
Sidelmann, Johannes J.; Kluft, Cornelis; Krug, Andrea H.; Winkler, Ulrich; Jespersen, Jørgen; Gram, Jørgen B.: Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women
706
Albrecht, Detlef; Ellis, David; Canafax, Daniel M.; Combs, Daniel; Druzgala, Pascal; Milner, Peter G.; Midei, Mark G.: Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant
Zusatzmaterial

Cellular Haemostasis and Platelets

718
Niezgoda, Piotr; Sikora, Joanna; Barańska, Malwina; Sikora, Adam; Buszko, Katarzyna; Siemińska, Emilia; Marszałł, Michał Piotr; Siller-Matula, Jolanta M.; Jilma, Bernd; Alexopoulos, Dimitrios; Fabiszak, Tomasz; Kubica, Jacek: Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina
727
Asher, Elad; Frydman, Shir; Katz, Moshe; Regev, Ehud; Sabbag, Avi; Mazin, Israel; Abu-Much, Arsalan; Kukuy, Andrew; Mazo, Anna; Erez, Aharon; Berkovitch, Anat; Narodistky, Michael; Barbash, Israel; Segev, Amit; Beigel, Roy; Matetzky, Shlomi: Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study
Zusatzmaterial

Endothelium and Angiogenesis

734
Esser, Jennifer S.; Saretzki, Erika; Pankratz, Franziska; Engert, Bianca; Grundmann, Sebastian; Bode, Christoph; Moser, Martin; Zhou, Qian: Bone morphogenetic protein 4 regulates microRNAs miR-494 and miR-126–5p in control of endothelial cell function in angiogenesis
Zusatzmaterial
750
Jia, Xin; Zhao, Chen; Chen, Qishan; Du, Yuxiang; Huang, Lijuan; Ye, Zhimin; Ren, Xiangrong; Wang, Shasha; Lee, Chunsik; Tang, Zhongshu; Li, Xuri; Ju, Rong: JAM-C maintains VEGR2 expression to promote retinal pigment epithelium cell survival under oxidative stress

Stroke, Systemic or Venous Thromboembolism

758
Heit, John A.; Armasu, Sebastian M.; McCauley, Bryan M.; Kullo, Iftikhar J.; Sicotte, Hugues; Pathak, Jyotishman; Chute, Christopher G.; Gottesman, Omri; Bottinger, Erwin P.; Denny, Joshua C.; Roden, Dan M.; Li, Rongling; Ritchie, Marylyn D.; de Andrade, Mariza: Identification of unique venous thromboembolism-susceptibility variants in African-Americans
Zusatzmaterial
769
Bochenek, Magdalena L.; Rosinus, Nico S.; Lankeit, Mareike; Hobohm, Lukas; Bremmer, Felix; Schütz, Eva; Klok, Frederikus A.; Horke, Sven; Wiedenroth, Christoph B.; Münzel, Thomas; Lang, Irene M.; Mayer, Eckhard; Konstantinides, Stavros; Schäfer, Katrin: From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension
Zusatzmaterial
784
Di Nisio, Marcello; Raskob, Gary; Büller, Harry R.; Grosso, Michael A.; Zhang, George; Winters, Shannon M.; Cohen, Alexander: Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists
Zusatzmaterial
794
Ageno, Walter; Dentali, Francesco; Pomero, Fulvio; Fenoglio, Luigi; Squizzato, Alessandro; Pagani, Giovanni; Re, Roberta; Bonzini, Matteo: Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome
801
Stuck, Anna K.; Spirk, David; Schaudt, Jil; Kucher, Nils: Risk assessment models for venous thromboembolism in acutely ill medical patients
809
Brekelmans, Marjolein P.A.; Scheres, Luuk J.J.; Bleker, Suzanne M.; Hutten, Barbara A.; Timmermans, Anne; Büller, Harry R.; Middeldorp, Saskia: Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin

Letters to the Editor

816
Giannarelli, Chiara; Rodriguez, David T.; Urooj Zafar, M.; Christoffel, Daniel; Vialou, Vincent; Peña, Catherine; Badimon, Ana; Hodes, Georgia F.; Mury, Pauline; Rabkin, Jacklyn; Alique, Matilde; Villa, Giulia; Argmann, Carmen; Nestler, Eric J.; Russo, Scott J.; Badimon, Juan J.: Susceptibility to chronic social stress increases plaque progression, vulnerability and platelet activation
Zusatzmaterial

Author Correspondence

819
Rosendaal, Frits R.; Cannegieter, Suzanne C.: Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear extrapolation: A comment
820
Biedermann, Joseph S.; van den Besselaar, A. M. H. P.; van der Meer, Felix J. M.; Adriaansen, Henk J.; Leebeek, Frank W. G.; Kruip, Marieke J. H. A.: Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply

Erratum

821
Erratum to Parasrampuria et al. “Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis” (Thromb Haemost 2015; 113: 719-727)